Edgewise Therapeutics, Inc. EWTX Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Edgewise Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edgewise Therapeutics, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edgewise Therapeutics, Inc.'s earnings yield?
- Edgewise Therapeutics, Inc. (EWTX) reported earnings yield of -5.2% in Q1 2026.
- How has Edgewise Therapeutics, Inc.'s earnings yield changed year-over-year?
- Edgewise Therapeutics, Inc.'s earnings yield increased by 25.3% year-over-year, from -7% to -5.2%.
- What is the long-term trend for Edgewise Therapeutics, Inc.'s earnings yield?
- Over 4 years (2021 to 2025), Edgewise Therapeutics, Inc.'s earnings yield has grown at a 3.1% compound annual growth rate (CAGR), from -5.7% to -6.4%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.